On The Pen

On The Pen

Home
Notes
Chat
Archive
About
There’s a Guy in Washington Fighting for Your GLP-1, and You’ve Probably Never Heard of Him
Meet Joe Nadglowski of the Obesity Action Coalition
 • 
On The Pen
Does Zepbound Stop Working?
And are higher doses coming?
 • 
On The Pen
8
Move Over Retatrutide, Protagonist Just Became Your Antagonist
You love to see competition!
 • 
On The Pen
4
Losing Zepbound Coverage? This Tool Might Give you and 80% Shot at Keeping It
TLDR: CVS dropped Zepbound today, but you do not have to accept the switch.
 • 
On The Pen
10

June 2025

If You Have Ever Loved Someone with Alzheimer’s, Hope May Be Near. Read This
New and Upcoming Semaglutide Data Will Change the Game
 • 
On The Pen
13
They Scanned Zepbound Users Brains… and Found Food Noise?
I’ve heard it a hundred times by now:
 • 
On The Pen
29
6:24
“Vikingtide” (VK2735)Enters Phase 3 and the Underdog Is Not Holding Back
over the past couple of years, this has been one of our favorite pipeline medications to track.
 • 
On The Pen
2
You Won’t Believe What Semaglutide Just Did in Type 1 Diabetes
We don’t usually get big updates on type 1 diabetes at these obesity conferences, but ADA 85 quietly gave us something surprising.
 • 
On The Pen
10
Maritide Results Leave Investors Feeling Pukey
We have been skeptical of MariTide for a while now, mostly because it makes trial participants want to close their eyes and pray for it to stop.
 • 
On The Pen
5
The Most Powerful Fat Loss Combo Ever? New Wegovy Trial Leaves Muscle Intact While Shredding 22% Body Weight
We just got fresh data from Eli Lilly, and it’s the kind of news that forces you to rethink what the next phase of obesity treatment might look like.
 • 
On The Pen
15
Lilly’s Rare ADA Investor Call: What Actually Mattered
We’re knee-deep in ADA 85 coverage, but Lilly just did something they rarely do.
 • 
On The Pen
3
Lilly’s Worst Nightmare: Compounders Directly Challenged Lilly’s Tirzepatide Patent In Court
We interrupt your regularly scheduled ADA updates to bring you this.
 • 
On The Pen
8
© 2025 David Knapp
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture